Dr Teri Heiland | Co-Founder And Sr Vice President Research And Development
Immunomic Therapeutics

Dr Teri Heiland, Co-Founder And Sr Vice President Research And Development, Immunomic Therapeutics

Dr. Teri Heiland is the Sr. Vice President of Research and Development at Immunomic Therapeutics and one of the founders of the Company. She has over 19 years of senior industry leadership experience. Her primary focus and expertise is in DNA vaccine design, optimization and development. In addition to her work to develop, shape and apply the LAMP technology platform, she has led multiple research teams to develop products and platform technologies. Dr. Heiland is also one of the founders of Capital Genomix, Inc. (CGI), a Maryland-based biomarker and drug discovery Company and served as its VP of Research and Development until 2006.
 As a key contributor to the Immunomix Executive team, Dr. Heiland plays a critical role in forging and achieving new research and development collaborations to further improve LAMP-Vax and develop new applications for the technology. In 2015, those efforts resulted in an exclusive license valued at over $300 million with Astellas Pharma for next generation allergy vaccines based on the LAMP platform.
Dr. Heiland is an inventor on multiple patents and was the principal investigator on grants from the Department of Defense and NIAID.  She received her Ph.D. in Molecular Immunology and Microbiology at the University of Missouri-Columbia.

Appearances:



April 16 Day 2 - 10 Co-conferences @ 09:40

Strategies to enhance vaccine acceptance in future generations

  • How have non-medical exemptions affected vaccine uptake in the US?
  • The vaccine education project: Laying the groundwork to ensure children and young adults are more accepting of vaccines in the future – what are the reasons that people are influenced by the anti-vaccine movement?
  • Developing a vaccine education curriculum for physicians to increase vaccine acceptance
  • What is the current and future role of digital/social media in shaping public perception around vaccination?
  • How can the media be used as a tool to aid scientists in getting out their message accurately? How can scientists communicate with journalists more effectively?
last published: 11/Apr/19 16:05 GMT

back to speakers

Sign Up for Event Updates

Get Involved At World Vaccine Congress Washington

 

To Sponsor Or Exhibit

Marc Rhys-Evans
marc.rhys-evans@terrapinn.com
+44 20 7827 5945

 

 

 

To Register

Tayyab Abbasi
tayyab.abbasi@terrapinn.com
+44 20 7092 1210

 

 

 

Press Relations

Karina Kusova
karina.kusova@terrapinn.com
+44 20 7092 1071